MedTrace Logo

Immune Profiling in Multiple Myeloma

NCT04135079 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-01-16

No results posted yet for this study

Summary

This study propose to investigate the immune repertoire of MM patients at the time of diagnosis vs. 1st vs. 2nd vs. 3rd relapse. This study will provide insights into the immune status of MM patients before and after disease transformation and help identify patients who will benefit from immunotherapy. It will also allow us to predict the efficacy of these immune-mediated strategies and their associated toxicity. By understanding the immune-microenvironment in MM patients during disease progression, the investigator will be able to better design immunotherapeutic strategies for maximal success.

Conditions

Sponsors & Collaborators

  • Mario Boccadoro

    lead OTHER

Principal Investigators

  • Alessandra Larocca · S.C. Ematologia U

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2021-04-28
Completion
2024-12-16

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04135079 on ClinicalTrials.gov